furaltadone

This page covers all furaltadone drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Mitogen-activated protein kinase 9.

Targets

Mitogen-activated protein kinase 9

Phase 2 pipeline (1)

• Furazolin · Other
  Furazolin works by inhibiting the activity of Mitogen-activated protein kinase 9 (MAPK9), a protein involved in cell signaling pathways.

Patent intelligence

• furaltadone patent landscape — aggregated cliff calendar, attackable patents, originator estates